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The protozoan Trypanosoma cruzi is the etiological agent of Chagas disease.
In immunosuppressed individuals, as it occurs in the coinfection with human
immunodeficiency virus (HIV), the central nervous system may be affected. In this
regard, reactivation of Chagas disease is severe and often lethal, and it accounts for
meningoencephalitis. Astrocytes play a crucial role in the environment maintenance of
healthy neurons; however, they can host HIV and T. cruzi. In this report, human astrocytes
were infected in vitro with both genetically modified-pathogens to express alternative
fluorophore. As evidenced by fluorescence microscopy and flow cytometry, HIV and
T. cruzi coexist in the same astrocyte, likely favoring reciprocal interactions. In this context,
lower rates of cell death were observed in both T. cruzi monoinfected-astrocytes and
HIV-T. cruzi coinfection in comparison with those infected only with HIV. The level of
HIV replication is significantly diminished under T. cruzi coinfection, but without affecting
the infectivity of the HIV progeny. This interference with viral replication appears to be
related to the T. cruzi multiplication rate or its increased intracellular presence but does
not require their intracellular cohabitation or infected cell-to-cell contact. Among several
Th1/Th2/Th17 profile-related cytokines, only IL-6 was overexpressed in HIV-T. cruzi
coinfection exhibiting its cytoprotective role. This study demonstrates that T. cruzi and
HIV are able to coinfect astrocytes thus altering viral replication and apoptosis.
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INTRODUCTION
Chagas disease is a chronic, infectious entity caused by the protozoan Trypanosoma cruzi (T. cruzi).
This disease is highly prevalent in Latin America and increasingly widespread in developed
countries (WHO, 2017a). According to the World Health Organization (WHO) an estimated 8
million people are infected worldwide, and 25 million people are at-risk of acquiring T. cruzi
infection (WHO, 2017b).
Trypanosoma cruzi parasites are classified into six groups (Discrete Typing Units, DTU I to
VI) based on genomic and molecular markers (Zingales et al., 2009; Cura et al., 2012). These
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groups share a phylogenetic relationship with some
eco-epidemiological, biological, and clinical defined behaviors
(Zingales et al., 2012). The parasite life cycle comprises the
infective bloodstream form (trypomastigote) able to infect
different nucleated cells. This complex process includes the
parasite-cell contact, an endocytic process with alteration
of cellular cytoskeleton, and development of a large vacuole
(parasitophorous vacuole) that hosts trypomastigotes. After
escape from it, the transformation to the amastigote form occurs
which multiply by binary division into the cytoplasm. During
this stage, the parasite maintains metabolic dependence on
nucleotide and fatty acid/glucose metabolisms, cellular energy,
and Akt-mediated prosurvival signaling (Caradonna et al., 2013).
At last, amastigotes differentiate into trypomastigotes, host cell
are lysed, and infective parasites are release to the bloodstream.
The acute phase of Chagas disease is characterized by high
parasitemia, broad tissue parasitism, and the development
of different evasion mechanisms that impair the specific
signoificnalty diminished immune response (Dosreis, 2011).
Although, the host immune system fails to eliminate the parasite,
it controls parasitemia when the chronic asymptomatic phase
is achieved (Coura and Borges-Pereira, 2010; Borges et al.,
2016).
During the evolution of the infection in immunocompetent
patients, around 30% develop myocarditis, megaesophagus,
and/or megacolon as the main manifestations of Chagas disease
(Kirchhoff et al., 2004). The involvement of the central nervous
system (CNS) is a severe life-threatening condition infrequent
in immunocompetent patients. However, this manifestation can
arise, as Chagasic meningoencephalitis, during the chronic phase
of infection in immunocompromised hosts, usually as a disease
reactivation (Bern et al., 2011). On immune-suppression therapy,
and in the context of human immunodeficiency virus/acquired
immune deficiency syndrome (HIV/AIDS) Chagas disease
reactivation lead to a severe and often lethal outcome (Pinazo
et al., 2013). Interactions between parasitic infections and
HIV/AIDS have been reported as well as the detrimental impact
on their natural history (Da Costa, 2000; Harms and Feldmeier,
2002; Sartori et al., 2002). Chagasic meningoencephalitis is
characterized by brain nodular reaction involving neutrophils,
microglia, astrocytes, and perivascular lymphocytic infiltrate
in various foci along the CNS (Lattes and Lasala, 2014).
Astrocytes, most abundant cells in brain that maintain an
adequate environment for neurons, have multiple functions
including endocytosis and antigen presentation (Jensen et al.,
2013). As other cells from nervous system, astrocytes can
host several infectious agents, including HIV and T. cruzi
(Blanchet et al., 2010; Vargas-Zambrano et al., 2013) pointing
them as important performers in Chagasic meningoencephalitis
development.
According to our knowledge, at present, there are no
in vitro studies describing interactions between T. cruzi
and HIV in CNS cells. Since both pathogens are able
to infect and replicate within astrocytes, we demonstrate
the cellular coexistence of T. cruzi and HIV as well as
the impact on both HIV replication efficiency and cell
death.
MATERIALS AND METHODS
Cell Lines and Trypanosoma cruzi Culture
A human astrocytoma cell line (U373 MAGI; NIH-AIDS
Reagents Program Cat# 3595) was used and maintained in
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 50 U of penicillin/ml, and 50mg
of streptomycin/ml (Sigma-Aldrich). This cell line was obtained
from the AIDS Reagent Program, National Institutes of Health
(NIH), USA. Three T. cruzi parasites were used: CL (DTU VI),
K98 (DTU I), and Sylvio (Sy, DTU I). The K98 strain was also
genetically modified to express the enhanced green fluorescent
protein (eGFP). Parasites were maintained in monolayers of
Vero cells. Trypomastigotes were harvested from supernatants by
low speed centrifugation (500 rpm, 10 min) after being released
from infected cells aimed at removing any contaminating cell
debris. Then, parasites were pelleted (2,500 rpm 10 min) and
finally resuspended in DMEM supplemented with 10% FBS, 50
U of penicillin/ml, and 50mg of streptomycin/ml (Andreani
et al., 2009; Aridgides et al., 2013). Parasites were counted in a
Neubauer chamber.
Preparation and Titration of HIV-1
Env-Pseudotyped Viruses, and Reporter
Virus Generation
pNL4-3 is a full-length infectious molecular clone of HIV-1
exhibiting X4 tropism. The NL4-3-GFPmolecular clone contains
the enhanced version of the green fluorescent protein gene
(eGFP) and an internal ribosome entry-site (IRES) inserted
upstream from the functional nef reading frames in the NL4-3
clone. An IRES element between the reporter gene and the HIV-
Nef drives the expression of eGFP. For this study, the additional
pNL4-3-DsRed (Discosoma sp. red fluorescent protein) reporter
virus was constructed by substituting the region of pNL4-
3-GFP which contains the eGFP gene instead of the DsRed
gene from Clontech. High-titer stocks of HIV-1-pseudotyped
with vesicular stomatitis virus envelope glycoprotein (VSV-
G) was constructed by cotransfecting 293T cells using a
VSV-G expression plasmid (Clontech) at HIV/VSV-G plasmid
ratio of 10:1. The supernatant was harvested 48 and 72 h,
filtered through a 0.45 µm filter and concentrated for over
5 h at 18,000 rpm. The pellet was resuspended in DMEM
supplemented with 10% FBS and stored at −86◦C until use.
The titer of virus stocks was adjusted to 100 ng/µl of p24
(HIV capsid protein). To determine whether HIV replication
correlated with GFP or DsRed expression in astrocytes, a time-
course analysis was performed following in vitro infection
of astrocytes with either HIV-GFP or HIV-DsRED. Three
different variables were monitored as a function of time: (1)
p24 concentration in cell culture supernatants (p24 ELISA
kit, INNOTEST R© HIV Antigen mAb), (2) p24 intracellular
expression using the KC57 monoclonal antibody against the
HIV p24 capsid protein (see below), and (3) HIV gene
expression by GFP and DsRED measurement by flow cytometry
(FACSCanto II flow cytometer, BD Biosciences, San Jose, CA,
USA). Besides, the flow cytometry analysis of cell fluorescence,
as a reflection of GFP or DsRED expression, allows the
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 August 2017 | Volume 7 | Article 345
Urquiza et al. Trypanosoma cruzi-HIV Coinfection in Astrocytes
identification of productively infected cells for each pathogen,
eventual cohabitation of both, and neighbor-uninfected cells
in a heterogeneous population. The flow cytometer sensitivity
and performance was checked prior to data acquisition using
Cytometer Setup & Tracking beads (BD Biosciences, San Jose,
CA, USA).
Timeline of HIV/Trypanosoma cruzi
Co-infection Assays
Human astrocytes were seeded in 48-well plates (3 × 104/well)
or Nunc R© Lab-Tek II chamber slides (103/well). Then, they
were exposed separately to T. cruzi and HIV-1 at an interval
of 24 h, according to two alternative schemes: (i), T. cruzi
before HIV (Tc/HIV), and (ii) HIV before T. cruzi (HIV/Tc).
For both schemes, prior to second pathogen exposure, astrocytes
were washed five times with fresh DMEM media to remove
free pathogens. Two HIV inocula were used (8, or 0.8
µg/ml measured as p24 antigen), while the infection with
T. cruzi trypomastigotes was carried out in a cell:parasite
ratio of 1:5. Under these conditions, T. cruzi infected-
astrocytes appeared to release trypomastigotes since 5 days post-
infection (dpi). After T. cruzi exposure, all measurements were
performed in cells and culture supernatants at 3 and 5 dpi in
triplicate.
All experiments were carried out in a BSL-3 laboratory at
the INBIRS. Following institutional rules, all biological materials
are mandatorily inactivated by autoclaving prior to disposal by
incineration. Incineration is carried out in a high-temperature
incinerator.
In vitro HIV and T. cruzi Infection: Analysis
by Flow Cytometry
The detection of intracellular HIV-1 p24 antigen was performed
using a monoclonal antibody (mAb) to the HIV-1 core antigen
labeled with fluorescein isothiocyanate (p24-FITC), following
the manufacturer’s recommended amount for all intracellular
staining. This mAb (KC57; Beckman Coulter, USA) identifies the
55, 39, 33, and 24 kDa species of the core antigens of HIV-1
(Chassagne et al., 1986; Darden et al., 2000).
Following infection with the DsRED or GFP-expressing
virus, and GFP-expressing parasite, the specific fluorescence was
measured. Cells were gated on the basis of side scatter and
forward scatter for debris exclusion. Subsequently, infected cells
were identified by their green or red fluorescence and evaluated
by different apoptosis assays (see below). Data from 5× 104 cells
were collected, stored, and analyzed with FlowJo X software for
Windows 7.0.
Astrocyte Apoptosis Measurement
Two different flow cytometry assays were performed in order to
evaluate astrocyte apoptosis.
Annexin-V/7AAD Staining
Plasma membrane permeability and phosphatidylserine cell
translocation were measured by flow cytometry in order to
define the percentage of early apoptotic cells. To this aim,
dual staining was performed with PE or APC-conjugated
Annexin-V and 7-amino-actinomycin D (7AAD) using the
Annexin-V/7AAD apoptosis detection kit (BD Biosciences).
Early apoptotic cells were defined as Annexin-V+/7AAD− cells
while those Annexin-V+/7AAD+ represented necrotic cells.
Percentages of Annexin-V and 7AAD were evaluated 3 and
5 dpi.
Caspase 3/7 Detection
The Vybrant R© FAM Caspase-3 and -7 Assay Kit uses an
approach to detect active caspases based on a fluorescent
inhibitor of caspases (FLICATM), essentially an affinity label. The
provider’s protocols were followed. For simultaneous evaluation
of caspases activation and membrane permeability, dual staining
with the FLICA reagent specific for caspase-3 and -7 and 7AAD
were evaluated by flow cytometry using a FACSCanto II (BD
Biosciences). We evaluated the activities of caspase-3 and -7 at
3 and 5 dpi.
Assessment of the Infectivity of the HIV
Progeny Using GHOST Cells
The infectivity of the HIV progeny was measured in supernatants
by the single-cycle infectivity assay in GHOST-CXCR4 cells
(Vodros and Fenyo, 2005). These are human osteosarcoma cells
that express a reporter gene (GFP) under the control of the long
terminal repeat (LTR) promoter of HIV-2. The GFP expression
occurs by Tat transactivation during HIV-1 infection. These
cells were maintained in DMEM supplemented with 10% FBS,
G418 (500 µg/ml), hygromycin (100 µg/ml), and puromycin
(1 µg/ml). Firstly, the p24 level in supernatants was measured
from HIV cultured in the presence and absence of T. cruzi.
Then, the p24 concentration was adjusted to 100 ng/ml. Finally,
the viral infectivity was evaluated using GHOST cells from the
supernatants. The proportion of GFP-positive cells was measured
by flow cytometry.
Quantification of Cytokines in Astrocyte
Culture Supernatants
Cytokines IL-2, IL-10, IL-4, IL-6, IFN-γ, TNF-α, and IL-17Awere
simultaneously measured 4 dpi with T. cruzi by flow cytometry
(BD FACSCanto flow cytometer, Biosciences, San Jose, CA, USA)
in culture supernatants using a cytometric bead array assay
(CBA) (Moncunill et al., 2013). The human Th1/Th2/Th17 kit
(BD Biosciences, San Jose, CA, USA) was applied following
manufacturer’s instructions. As reported previously, the limits of
detection of each cytokine are 0.1 pg/ml (IL-2), 0.03 pg/ml (IL-4),
1.4 pg/ml (IL-6), 0.5 pg/ml (IFN-γ), 0.9 pg/ml (TNF-α), 0.8 pg/ml
(IL-17A), and 16.8 pg/ml (IL-10) (Souto et al., 2014). Quantitative
analyses were performed using FCAP Array v1.0.1 software (Soft
Flow Inc., Pecs, Hungary). Four days after T. cruzi infection, the
level of IL-1β in supernatants was quantified for each condition
(BD cytokines ELISA Kit).
IL-6 activity was blocked using a neutralizing monoclonal
antibody (mouse anti-human IL-6, R&D Systems Inc.
Minneapolis, MN) which was added to the culture at 0.2
µg/ml 1 day after HIV exposure. Cells were also incubated
with isotype control immunoglobulin G1 (R&D Systems Inc.
Minneapolis, MN).
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Astrocytes Exposure to Recombinant
Trypanosoma cruzi Trans-Sialidase (TS)
Protein (Enzymatically Active, and Inactive
Isoforms)
TS was expressed in Escherichia coli BL21 and purified to
homogeneity by immobilized metal affinity chromatography
through Ni2-charged Hi-Trap chelating columns (GE
Healthcare) and ion-exchange chromatography (Mono Q;
GE Healthcare) as described previously, followed by passage
through a polymyxin column (Pierce) for endotoxin depletion
(Leguizamon et al., 1999). As described above (Section Timeline
of HIV/Trypanosoma cruzi Co-infection Assays), astrocytes were
exposed to 1 µg/ml of TS (active, or inactive isoform) according
the Tc/HIV timeline (Figure 2A) replacing trypomastigotes.
In vitro Herpes Simplex-2 Virus (HSV-2) and
T. cruzi Infection: Viral Replication
Measurement
Analysis by Plaque-Forming-Units Assay in Vero Cells
Vero cells (African green monkey kidney cells) were cultured in
DMEM 5% SFB at a concentration of 3 × 106 per well. Cells
infection with T. cruzi trypomastigotes was carried out in a
cell:parasite ratio of 1:5 when 80% confluence was achieved. Vero
cells were washed five times with fresh DMEM media to remove
free parasites and 24 h after T. cruzi infection were exposed to
HSV-2 (G-strain) using differentmultiplicity of infection−m.o.i-
in 300 µl of DMEM. After 2 h cells were washed with PBS and
cultured in DMEM 10% plus 0.8% methylcellulose restrictive
media. After 48 h, cells were fixed with 1% paraformaldehyde
for an hour and then stained with crystal violet. Cytophatic effect
(cell lysis) was semi-quantitatively evaluated (from no visible [0]
to maximum [++++]). This assay was carried out by duplicate.
HSV-2 DNA Quantification by qPCR
Total DNA was obtained from 200 µl supernatants of 1 ×
106 Vero cells infected with 1 × 104 plaque forming units
(pfu) of HSV-2 using PureLink DNA viral extraction kit
(Thermo Scientific). Quantitative real-time PCR was performed
using SYBR Green PCR Master Mix (Invitrogen) in 20 µl
reaction. All primers were used at a concentration of 300 nM.
Primers for HSV-2 were 5′-CGCATCATCTACGGGGACACG
GA-3′ (forward) and 5′-ATGACGCCGATGTACTTTTTCTT-3′
(reverse). Reactions were carried out in StepONE Plus cycler
(Thermo Scientific). The cycling program used was 95◦C for 10
min followed by 40 cycles of 95◦C for 15 s and 60◦C for 60 s.
Threshold values (Ct) were used to compare directly. Values are
expressed as fold-change compared to the control group.
Assay to Evaluate Benznidazole Effect on
Apoptosis and Viral Replication in
Astrocytes Exposed to T. cruzi and HIV
Astrocytes cultured at 37◦C and infected at a cell:parasite ratio
of 1:5 were incubated following identical conditions as described
previously, and then washed five times with fresh DMEMmedia.
Infected astrocytes were cultured and treated for 24 h with 10
µMof benznidazole (Laboratorio ELEA, Argentina), and washed
again with fresh DMEMmedia. Then, these cells were exposed to
HIV following the timeline described previously.
Assessment of T. cruzi Effects on HIV-1
Replication Using Transwell Assays
The ability of T. cruzi infected-astrocytes and/or T. cruzi free-
trypomastigotes to inhibit HIV-1 replication through soluble
mechanisms was evaluated using a transwell strategy. To achieve
this goal, culture plate inserts were used with membrane-based
devices for use with standard plastic cell culture plates. The
inserts are made of a polycarbonate membrane in polystyrene
plastic holders with 0.4 µm diameter pore µm which allows
different conditions for coexistence without intercellular contact.
The infection strategy was as follows: HIV-infected astrocytes
at the bottom chamber, and the inserts containing astrocytes
infected with T. cruzi, T. cruzi free-trypomastigotes. In both
chambers, uninfected cells were used as controls.
Fluorescence Microscopy
Astrocytes were cultured in Nunc R© chamber slides and infected
alternatively, by two Trypanosoma cruzi parasites (K98 or, CL)
in the presence or absence of HIV. Cells were washed thrice
to remove free parasites, and then labeled dually for HIV (p24
KC57-FITC antibody, Beckman Coulter) and T. cruzi at 2, 4, 6,
and 8 dpi. The presence of intracellular amastigotes was evaluated
using rabbit polyclonal anti-T. cruzi antibody (kindly donated
by Dr. Federico Penas, Instituto de Microbiología y Parasitología
Médica -IMPAM- Facultad de Medicina, Universidad de Buenos
Aires, Argentina). Then, a commercial goat anti-rabbit IgG
(H+L) secondary antibody, Alexa Fluor 647 (Invitrogen, Thermo
Fisher) was used. Nuclei were stained with DAPI. The coverslips
mounted with DAPI Fluoromount-G (SouthernBiotech) were
studied in a Nikon Eclipse Ti-S L100 fluorescence microscope
using a Plan Apochromat 60× 1.42 NA oil immersion objective.
Images were analyzed using the NIS-Element software.
Statistical Analysis
Where applicable, the two-sided Student’s t-test was used to
determine statistical significance. A P < 0.05 was considered
significant (∗), <0.01 highly significant (∗∗), and <0.001 (∗∗∗).
For multiple comparisons, ANOVA analysis was performed.
Results presented with error bars represent mean± SEM.
RESULTS
Trypanosoma cruzi and HIV-1 Are Able to
Infect Astrocytes Even Simultaneously but
Carrying an Impairment on the HIV
Infection Rate
HIV and T. cruzi are able to infect separately human astrocytes
(Churchill et al., 2009; Vargas-Zambrano et al., 2013). Our first
aimwas to elucidate their capability to coinfect human astrocytes,
even their cellular coexistence, as well as the reciprocal impact on
their infection rate. For these goals, we examined the infection
rate in three distinguishable conditions, including each pathogen
monoinfection, and coinfection. First, the monoinfection rate of
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T. cruzi in astrocytes (evaluated as percentage of cells exhibiting
amastigotes) and the number of amastigotes per infected cell were
measured at 2, 4, 6, and 8 dpi. The first amastigotes were observed
at 2 days after exposure toT. cruzi (strain CL, or K98). Figure 1AI
shows the percentage of astrocytes infected by T. cruzi, whereas
Figure 1AII illustrates the intracellular amastigotes increase over
time, and incipient trypomastigotes release at 8 dpi.
Regarding the HIV monoinfection, the infection rate on
astrocytes at 2 dpi reached 20.0± 1.5% (measured as intracellular
p24 antigen expression) and was increased up to 43.3 ± 2.7%
at 4 dpi; such a rise continued slightly (48.2 ± 3.1) at 8 dpi
(Figure 1B).
In double infection assays, when astrocytes were first exposed
to T. cruzi and then to HIV, (Figure 1C), at 5 dpi, T.
cruzi and HIV cellular cohabitation was clearly evidenced by
both flow cytometry (Figure 1D) and fluorescence microscopy
(Figure 1E). However, this phenomenon was observed with a
significantly lower frequency (2.5 ± 0.5%) in comparison with
HIV (13.1± 1.7%) and T. cruzi (Tc 10.5± 1.7%) monoinfections
(Figure 1D). Furthermore, a significant diminishing was denoted
in the HIV infection rate at 3 dpi (HIV 25.7 ± 1.0% vs. Tc/HIV
10.2± 0.5%) and 5 dpi (HIV 37.7± 1.2% vs. Tc/HIV 15.9± 0.4%;
Figure 1F).
Cytoprotection Is Observed on Astrocytes
Infected with Trypanosoma cruzi and
Exposed to HIV
At this point, it was relevant to accomplish whether the
diminished rate of HIV infection on astrocytes was related
to the increased cellular apoptosis during the coinfection. For
this aim, the level of apoptosis was evaluated among astrocytes
in the three experimental conditions (HIV monoinfection, T.
cruzimonoinfection, and T. cruzi/HIV coinfection following the
scheme of Figure 2A). For this purpose, Annexin-V/7AAD and
the active forms of caspase-3 and -7 were measured. In HIV
monoinfection, Annexin-V/7AAD level at 3 and 5 dpi (17.8
± 1.6 and 20.7 ± 0.1%, respectively) was significantly higher
than T. cruzi/HIV coinfection (9.9 ± 1.0 and 14.9 ± 1.5%,
respectively) and T. cruzi monoinfection (7.9 ± 1.9 and 11.0 ±
0.8%, respectively; Figure 2B). Similarly, the caspase-3 and -7
activation level was significantly higher in HIV monoinfection
(8.9 ± 0.2%) than T. cruzi/HIV (7.2 ± 0.3%) and T. cruzi
monoinfection (2.1 ± 0.3%) at 3 dpi (Figure 2C). The apoptosis
level among T. cruzi monoinfected astrocytes exhibited no
differences in comparison with non-exposed cells.
During HIV and/or T. cruzi astrocytes infection, cells are
accompanied by non-infected neighbor ones, as observed in
Figures 1D,E. To evaluate and discriminate their apoptosis level,
astrocytes were exposed to HIV-DsRed and T. cruzi-GFP, and
apoptosis was measured with Annexin-V (APC)/7AAD. This
strategy allowed us to discern cell death among infected and
bystander (exposed, non-infected) cells (Figure 2D). At 3 dpi,
the total level of apoptosis among astrocytes exposed to HIV
was 12.7 ± 0.1% of which 5.5 ± 0.8% was contributed by the
productively HIV-infected cells. Among T. cruzi infected cells,
the total apoptosis level was 6.8 ± 0.7%, of which 1.6 ± 0.2 was
due to infected astrocytes. In T. cruzi/HIV assays, total apoptosis
level was 10.5 ± 0.9%, where three distinguishable scenarios are
observed: productively coinfected-cells contributed with 2.5 ±
0.4%, mono infected T. cruzi astrocytes with 2.4 ± 0.1%, and
monoinfected HIV cells with 3.4± 0.4%. Therefore, non-infected
astrocytes suffer apoptosis as a consequence of a bystander effect
induced by pathogens exposition: HIV: 7.7 ± 1.1%, Tc: 4.5 ±
0.2%, and Tc/HIV: 3.6± 0.8%.
Similarly, at 5 dpi (Figure 2D) astrocytes exposed only to HIV
depicted a total apoptosis level of 21.9 ± 0.2% (13.0 ± 0.8%
among productively infected cells); cells exposed only to T. cruzi
exhibited a total apoptosis level of 10.4 ± 0.2% (including a
4.8 ± 0.9% among parasite-infected cells). The total apoptosis
level of astrocytes exposed to both pathogens was 19.5 ± 0.4%
that included those found in HIV, T. cruzi, and T. cruzi/HIV
productively infected-cells (5.8 ± 0.1, 3.0 ± 0.3, 6.6 ± 0.3%,
respectively). The contribution to apoptosis due to the bystander
effect induced by HIV, T. cruzi, or both was 9.2 ± 0.5, 6.3 ± 0.2,
and 4.9± 0.4%, respectively.
HIV-Trypanosoma cruzi Coinfection
Induces IL-6 Overexpression Which
Influences Apoptosis Level
The HIV replication is strongly related to the level of cellular
activation. Such a cellular status is, among others, associated with
the type and level of circulating cytokines (Rosenberg et al., 1997).
The concentration of IL-1β, IL-2, IL-10, IL-4, IL-6, IFN-γ, TNF-
α, and IL-17A cytokines was quantified at 5 dpi in astrocyte
culture supernatants in the three experimental conditions (each
monoinfection, and coinfection; Figure 3A). IL-6 was the only
one to reach quantifiable levels for both HIV monoinfection
and T. cruzi/HIV coinfection scenarios. Significant higher levels
in coinfected astrocytes were found (1293.4 ± 13.8 pg/mL)
compared to those exposed only to HIV (860.0 ± 5.0 pg/mL),
or T. cruzi (424.2± 57.3 pg/mL; Figure 3B).
Among the different conditions assayed, significantly higher
levels of apoptosis (Annexin-V/7AAD) were observed after
blocking IL-6 using a neutralizing monoclonal antibody:(i) HIV-
monoinfected cells (24.2 ± 0.7 vs. 18.6 ± 0.7%), and (ii) HIV/Tc
coinfected astrocytes (18.6 ± 0.6 vs. 15.1 ± 0.6%; Figure 3C).
Thus, considering that IL-6 participates on cytoprotection, its
overexpression may contribute to the reduction of apoptosis
observed during T. cruzi/HIV coinfection.
Trypanosoma cruzi Infection Alters the HIV
Replication in Astrocytes
As we described above, HIV infection rate is altered in
an established T. cruzi infection. In order to elucidate if
parasite modify astrocytes permissiveness to viral infection, two
experimental approaches were carried out. First, we inverted
the order of the timeline of pathogen exposure (Figure 4).
Hence, astrocytes were first exposed to HIV, and 24 h later to
T. cruzi; measurements were carried out at 5 dpi. Under this
schedule, both HIV infection rate (measured as intracellular
GFP-expression) and its level of replication (measured as p24
production in culture supernatants) were significantly lower
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FIGURE 1 | In vitro HIV and Trypanosoma cruzi infection of astrocytes. Astrocytes were separately exposed to Tc (AI,II), and HIV (B), and their monoinfection curves
were determined by intracellular immunostaining and cytofluorimetric analyses at the indicated time points, respectively. The frequency of Tc (AI), the intracellular
amastigotes burden (AII) and HIV (B)-infected astrocytes are represented; figures (AI,B) show mean values ± SD of two experiments performed in triplicate. Then,
(Continued)
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FIGURE 1 | Continued
Tc/HIV coinfection assays were performed according to the timeline depicted in (C). (D) Flow cytometry was used to characterize Tc and/or HIV infection status of
cultured astrocytes by determining the frequencies of Tc-DsRED+, and HIV-GFP+ cells. (E) Fluorescence microscopy showing Tc (Red: K98- Alexa fluor 647-labeled
intracellular amastigotes) and/or HIV (Green: p24 FITC-labeled) infected-astrocytes at 5 dpi. Cell and parasite nucleus were stained by DAPI (blue). (F) The impact of
Tc coinfection on the HIV-infection rate (measured by cytofluorimetric analysis as percentages of GFP+ cells) at 3 and 5 dpi is represented. Significant differences were
assessed by an unpaired t-test and are indicated by *P < 0.05 and **P < 0.01, respectively.
when T. cruzi coexists (HIV 39.5 ± 1.8% vs. HIV/Tc 34.8 ±
2.2% and HIV 280.7 ± 6.5 ng/ml vs. HIV/Tc 220.4 ± 5.4 ng/ml,
respectively; Figures 4A,B). Such detrimental effects appear to be
parasite-dependent considering that cell viability was preserved -
or even it was higher- among coinfected astrocytes in comparison
with HIV-monoinfected cells (Figure 4C). These observations
prompted us to conclude that the presence of T. cruzi affects HIV
replication irrespectively of their order to infect astrocytes.
Second, it is expected that according to T. cruzi infection
progress (increment of infected cells and number of amastigotes
per cell) its detrimental influence on HIV replication should
be more pronounced. For this goal, we compared the level of
viral replication between HIV-monoinfected and HIV-T. cruzi
coinfected astrocytes at 3 and 5 dpi, following the scheme
Figures 4D–G. This procedure was performed using (a) HIV-
expressing GFP with further flow cytometry evaluation, and
(b) quantification of the HIV p24 antigen expression at both
intracellular (by flow cytometry) and extracellular (by ELISA)
levels. As described above (Figure 1F), the flow cytometry
analysis revealed that the percentage of HIV-infected cells was
significantly lower in the T. cruzi/HIV condition at 3 dpi, and
even more at 5 dpi. At the individual cell level, the quantitative
measurement of HIV replication was inferred by the mean
fluorescence intensity (MFI). A significant reduction was also
observed when HIV and T. cruzi coexist (HIV 3588.0 ± 263.0
vs. Tc/HIV 1417.5 ± 30.0, at 5 dpi; Figure 4D). Similarly, the
expression level of extracellular p24 antigen was lower in HIV/T.
cruzi (98.0 ± 4.0 ng/ml) than in HIV-monoinfection (206.0 ±
19.0 ng/ml; Figure 4E, at 5 dpi). Coincidentally, the rate of cells
expressing intracellular p24 antigen (HIV 25.0± 0.7% vs. Tc/HIV
11.5 ± 0.5%; Figure 4F, at 3 dpi) as well as the quantitative
expression level of intracellular p24 (as MFI: HIV 7638.5 ±
183.1 vs. Tc/HIV 5094.0 ± 43.8; Figure 4G) were also markedly
diminished in T. cruzi co-presence.
HIV Replication Modulated by
Trypanosoma cruzi: Effect of Benznidazole
Treatment and Parasite Multiplication Rate
The parasite-related downregulation on the HIV replication on
astrocytes may be related to T. cruzi multiplication rate. To
analyze this association we inhibited T. cruzi multiplication
using benznidazole (BZN), a trypanocidal agent. Then, both
apoptosis level (Annexin-V/7AAD) and HIV replication (p24
antigen in supernatant) were measured among astrocytes in
the three experimental conditions (HIV monoinfection, T. cruzi
monoinfection, T. cruzi/HIV coinfection). After BZN treatment
the level of cell death was increased when comparing against
BZN-untreated T. cruzi-infected astrocytes (Tc monoinfection:
13.7 ± 2.0 vs. 8.8 ± 1.8%; Tc/HIV coinfection: 24.3 ± 0.5 vs.
20.5 ± 1.4%, with and without BNZ, respectively; Figure 5A). In
line with this, HIV replication level was significantly higher in
BZN-treated HIV/Tc coinfected cells than untreated cells (91.0±
9.5% vs. 42.2 ± 12.8 ng/ml). The HIV replication among HIV-
monoinfected cells exhibited no differences regarding the BZN
treatment (Figure 5B).
Furthermore, other approach was carried out to study the
relationship between parasitemultiplication andHIV replication.
We compared the impact of two different T. cruzi strains
(K98 and Sylvio), that display different multiplication rate in
astrocytes (measured as number of amastigote per cell). Fixing
the astrocyte:Sy (Sylvio) inoculum to 1:10, and K98 to 1:5 similar
infection rates were achieved (22.1 ± 3.7%) but multiplication
rate was significantly lower for Sy than K98 parsaites (7.2 ± 3.8
and 21.1 ± 7.4 amastigote/cell, respectively). Then, astrocytes
were exposed to equal HIV inoculum and the viral replication
was measured (level of extracellular p24 in culture supernatants).
The HIV replication in monoinfection was 122.3 ± 10.8
ng/mL, whereas in coinfection assays significant decreases were
observed. While Sy strain induces viral replication diminishing
(101.7± 2 ng/mL), K98, a more replicative strain, induces a more
pronounced effect (80.9 ± 1.9 ng/mL; Figure 5C). Altogether,
our results strongly suggest that T. cruzi impairment on HIV
replication is associated to parasite multiplication.
Trypanosoma cruzi Does Not Alter the
Infectivity of the HIV Progeny
The reduced HIV replication could also be ascribed to
diminished infectivity when some defects in the viral progeny
are caused. We further examined the plausible T. cruzi influence
on HIV infectivity using GHOST cells and flow cytometry. No
significant differences in the infectivity of the HIV progeny were
found at 3 days post-exposition, thus inferring that T. cruzi
does not modify the replication efficiency of the HIV progeny
(Figure 6).
Soluble Factors Are Involved in HIV
Replication Impairment by Trypanosoma
cruzi
As we described previously, T. cruzi decreases the HIV
replication. It is hardly associated withHIV-T. cruzi cohabitation,
due to its low frequency observed. To assess if cell-to-cell
contact is needed to attain this effect, we used a transwell R©
device that define two distinguishable cellular environments
(Figure 7A). Astrocytes infected with HIV in the bottom
chamber were exposed to the transwell chamber with (i) T. cruzi-
infected astrocytes, and (ii) free trypomastigotes. As control,
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FIGURE 2 | Apoptosis of astrocytes after Trypanosoma cruzi and HIV exposure. (A) Infection timeline (B) Flow cytometric apoptosis assay (Annexin V/7AAD) on
astrocytes upon exposure to Tc, HIV, or combination (Tc/HIV). Percentage of apoptotic cells at 3 and 5 dpi is shown. Mean values ± SD from three different
experiments. Statistical significance for each condition vs. pathogen unexposed control, or between conditions is indicated by asterisk(s). Two-tailed paired Student
(Continued)
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FIGURE 2 | Continued
t-test P-values indicate statistical significance (*P < 0.05 and **P < 0.01). (C) Caspase 3–7 activation measured by FLICA (fluorescently labeled inhibitors of caspasas)
combined with plasma membrane permeability assessment (propidium iodide; PI) after exposure to Tc, HIV, or both (Tc/HIV) (**P < 0.01 and *P < 0.05 compared with
the pathogen unexposed control). (D) Flow cytometric apoptosis assay (Annexin V-APC/7AAD) on astrocytes distinguishing for each productively-infected pathogen
status (Tc, HIV, and Tc/HIV) at 3 and 5 dpi.
FIGURE 3 | IL-6 level according to infection status and effect of IL-6 blocking assay on apoptosis. (A) Infection timeline. (B) IL-6 levels were evaluated in culture
supernatant by ELISA at 5 dpi for each condition. (C) Flow cytometric apoptosis assay (Annexin V/7AAD) on astrocytes upon exposure to Tc, HIV, or combination
(Tc/HIV). For each condition is also shown the IL-6 blocking assay. IgG1 isotype controls (“isotype Ab”) were included for each condition. Percentage of apoptotic cells
at 5 dpi is shown. Mean values ± SD from three different experiments. Statistical significance for each condition vs. pathogen unexposed control, or between
conditions is indicated by asterisk(s). Two-tailed paired Student t-test P-values indicate statistical significance (*P < 0.05, **P < 0.01, and ***P < 0.001).
uninfected astrocytes were included. At 5 dpi, HIV replication
(as extracellular p24 level) and apoptosis were measured in the
bottom chamber. The HIV replication (133.6 ± 19.9 ng/mL)
was significantly lower when they were exposed to T. cruzi,
either parasite-infected astrocytes (77.9 ± 18.7 ng/mL), and
free-parasites (92.8 ± 9.0 ng/mL). Hence, both T. cruzi stages
(intracellular amastigotes and extracellular trypomastigotes)
are able to alter viral replication remoteness (Figure 7B).
Considering IL-6 overexpression findings (Figure 3) we evaluate
it following the same transwell device. The IL-6 level from
HIV-monoinfected astrocytes (867.9 ± 190.3 pg/mL) were
increased when HIV-infected astrocytes were opposed to
T. cruzi infected cells (1186.2 ± 101.4 pg/mL) but not when
were opposed to free-trypomastigotes (334.7 ± 12.9 pg/mL;
Figure 7C).
Taken together, IL-6 upregulation is independent of HIV-T.
cruzi intracellular cohabitation and cell-to-cell contact. On the
other hand, the influence of T. cruzi on HIV replication depends
on soluble factors released by parasites either from infected cells
and/or by trypomastigotes.
Trypanosoma cruzi Infection Reduces
Herpes Simplex Type-2 (HSV-2) Replication
In order to elucidate that T. cruzi infection diminishes viral
replication not only for HIV, we assessed the parasite effect on
viral replication for HSV-2, as alternative neurotrophic virus.
Viral replication was measured using a semiquantitative viral
plaque assay and quantification of viral DNA in cell culture
supernatant. The magnitude of cytophatic effect on Vero cells
(cellular lysis) decreased proportionally according to the three
HSV-2 inoculums (m.o.i) being maximum [++++] for m.o.i=
0.1, intermediate [+++] form.o.i= 0.01, and low [++] form.o.i
= 0.001. The cellular lysis grade decreased substantially for each
viral inoculum (from very low [+] to not visible [0], respectively)
when Vero cells were previously exposure to T. cruzi. Similarly, a
marked lower (7.6 fold-change) HSV-2 DNA was detected when
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FIGURE 4 | Trypanosoma cruzi impairs HIV-1 replication in astrocytes. Effect of Tc superinfection on HIV replication rate measured by cytofluorimetric analysis as
GFP+ cells (A), and by p24 level in culture supernatant expressed in ng/ml) measured by ELISA (B) at 5 dpi. (C) Cell viability measured by flow cytometry as the
percentage of propidium iodide positive cells (PI+) at 5 dpi. (**P < 0.01 and *P < 0.05). (D) Quantitative analysis of HIV-GFP positive cells proportion and mean
fluorescence intensity (MFI) measured by flow cytometry at 5 dpi. (E) Tc impact on HIV replication rate measured as p24 level (in culture supernatant expressed in
ng/ml) at 3 and 5 dpi. (F) Tc impact on HIV replication rate measured by flow cytometry analysis of intracellular p24-FITC expression at 3 and 5 dpi (**P < 0.01 and
*P < 0.05). (G) Quantitative analysis of p24-FITC+ cells and mean fluorescence intensity (MFI) measured by flow cytometry at 5 dpi.
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FIGURE 5 | (A,B) Benznidazole (BZN) effect on apoptosis and viral replication in astrocytes exposed to T. cruzi and HIV. (A) Flow cytometric apoptosis assay (Annexin
V/7AAD) on astrocytes upon exposure to Tc, HIV, or combination (Tc/HIV) treated (or not) with BZN. Percentage of apoptotic cells at 3 dpi is shown. (B) Comparative
HIV replication measured as p24 level concentration in culture supernatant (by ELISA) in monoinfected, and T. cruzi-coinfected astrocytes treated (or not) with BZN.
(C) Comparative analysis of different Tc parasites (K98, Sy) impact on HIV replication and cell viability (measured by ELISA as p24 culture supernatant, and propidium
iodide positive cell -PI+- levels, respectively). Mean values ± SD from three different experiments. Significant differences were assessed by an unpaired t-test and are
indicated by (*P < 0.05, **P < 0.01, and ***P < 0.001).
T. cruzi and HSV-2 coinfected Vero cells in comparison with
HSV-2 monoinfection (Figure 8).
DISCUSSION
The natural history of T. cruzi infection could be modified
by immunosuppression in most patients with Chagas disease
predisposing them to a reactivation episode. In them, a
more severe clinical presentation (e.g., central nervous system
involvement and severe myocarditis) is observed compared to
immunocompetent patients with acute Chagas disease (Pinazo
et al., 2013). Mass lesions in the white matter of the brain
are the most frequent clinical findings, but meningitis and
meningoencephalitis may also occur (Sica et al., 2008; Pinazo
et al., 2013). This CNS involvement was reported in 75–80% of
patients coinfected with T. cruzi and HIV, being more frequent
than myocardial damage (Sartori et al., 1995, 2007; Cordova
et al., 2008). Reciprocal interactions between both pathogens are
suspected to occur in CNS cells but to date no data is available yet.
Glial cells are an important source of CNS cytokines and
chemokines and they might likely contribute actively in the
physiopathology of T. cruzi infection. In murine models, glia
but not neurons harbor amastigotes (Roffe et al., 2003; Rachid
et al., 2010). On the other hand, the astrocytoma is the only
CNS human cell line reported to be susceptible to T. cruzi
infection (Vargas-Zambrano et al., 2013). Astrocytes, the main
cells in brain tissues (Seth and Koul, 2008), participate in the
environment maintenance of neurons as well as in immune
functions producing cytokines and chemokines. They can host
several infectious agents, including HIV, appearing to be themost
abundant HIV-infected cell of the CNS (Dewhurst et al., 1987;
Churchill et al., 2009), therefore contributing predominantly to
the neurotoxicity commonly observed during the chronic stage of
HIV infection. However, it is unknown whether the coexistence
of both pathogens in the same astrocyte is possible, as well as its
consequences.
The present study shows that HIV and T. cruzi are able to
coexist in human astrocytes as a phenomenon that lasts over time.
Moreover, such coexistence was possible regardless of the order
in which both pathogens entered. However, cellular cohabitation
showed a significantly lower frequency than the unique infections
of each pathogen. In this scenario, reciprocal interactions
between both pathogens could be enhanced considering that
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FIGURE 6 | Trypanosoma cruzi effects on infectivity of the HIV progeny. GFP
expression in GHOST cell culture inoculated with supernatant from HIV and
Tc/HIV was measured by flow cytometry at 3 dpi. Mean values ± SD from
three different experiments. No significant differences were found between the
two conditions (>0.05).
their multiplication appeared to occur. In this regard, a
T. cruzi-mediated detrimental effect on HIV replication was
reported previously on macrophages and human placenta cells
(Dolcini et al., 2008; Andreani et al., 2009).
It is known that HIV exhibits a pro-apoptotic potential
not only among productively infected cells but also among
non-infected ones as a bystander effect (Eugenin and Berman,
2013). In contrast, T. cruzi displays a cytoprotective role by
inhibiting apoptosis in several cell types (Nakajima-Shimada
et al., 2000; Schaumburg et al., 2006). Here, we observed that
this cytoprotection ability is still conserved under concomitant
HIV infection. Interestingly, the cytoprotection was reversed
when the parasite development was inhibited by the treatment
of T. cruzi-infected cells with benznidazole. Furthermore, we
observed a significantly diminished HIV progeny size when
T. cruzi infection occurred as a previous (Figure 4E) or a
subsequent event (Figure 4B), as well as T. cruzi (Figure 8B) is
able to impact negatively on HIV replication irrespectively of
their cellular cohabitation and/or infected cell-to-cell contact, or
even HIV-infected cell-to-free trypomastigotes contact.
Resident astrocytes are involved in CNS inflammation after
trauma or infection (Cooley et al., 2014) by secreting host-cellular
factors such as IL-6 (Norenberg, 1994; VanWagoner et al., 1999).
This cytokine is considered a neuropoietin that participates
in neurogenesis as well as responding to normal and damage
conditions of mature neurons and glial cells (Erta et al., 2012;
Liu and Kumar, 2015). We observed that T. cruzi monoinfected
astrocytes did produce IL-6 similarly to uninfected control cells,
in agreement with recently reported results (Duran-Rehbein
et al., 2017). However, increased levels of IL-6 were observed in
HIV/T. cruzi coinfected astrocytes. Such IL-6 level was observed
independently of cell coexistence of the pathogens, and cell-to-
cell contact as well, thus depending of parasites soluble factors.
In agreement, by IL-6 blocking we could induce an increment
of apoptosis revealing its participation in the cytoprotection
observed.
Both astrocytes infected by neurotropic viruses such as
herpes simplex (Detje et al., 2015; Lindqvist et al., 2016) or
the intracellular amastigotes of T. cruzi (Costa et al., 2006;
Koga et al., 2006) induce the release type I-IFNs capable
of inhibiting HIV-1 replication in cell culture (Ikeda et al.,
2015a,b). Here, when we assessed herpes simplex virus-T. cruzi
coinfection in non-producing type I-IFNs Vero cells (Osada
et al., 2014) the parasite-related cytoprotective role was also
observed. Free trypomastigotes are equally capable of stimulating
IFNs-I released via activation of TLR2 through parasite-derived
ligands (Campos et al., 2001) that may have an impact on the
infection outcome by conditioning the host environment and
the immune response. Among these ligands, we evaluated the
role of trans-sialidase (TS), a trypomastigote well characterized
virulence factor secreted in vesicles and involved in immune
evasion (Mucci et al., 2017), pathogenesis (Leguizamon et al.,
1999; Mucci et al., 2002; Risso et al., 2007; Freire-De-Lima et al.,
2015), and also proposed as a neuroprotective factor (Chuenkova
and Pereiraperrin, 2011). However, neither inactive nor active
TS isoforms (data not shown) appear to propitiate the parasite
detrimental effect on HIV replication in astrocytes. Considering
that other parasite-secreted proteins may influence the immune
response (Watanabe Costa et al., 2016), further research is
deserved.
Several studies revealed that different T. cruziDiscrete Typing
Units (DTUs) participate in human T. cruzi—HIV coinfection
(Perez-Ramirez et al., 1999; Lages-Silva et al., 2002; Burgos
et al., 2005; Hernandez et al., 2014). Moreover, in a multiclonal
infection involving DTUs I and V/VI, we reported that CNS
histotropism was ascribed to a DTU I population as the
etiological agent of meningoencephalitis (Burgos et al., 2008).
Here, the in vitro detrimental effect on HIV progeny production
was shared by two different parasites belonging to DTU I
(K98 and Sylvio), but with a dissimilar impact. Hence, under
comparable levels of parasite infection rates, the HIV replication
decline induced by K98 was higher than the induced by Sylvio
strains. This was related to the higher rate of multiplication
of K98 strain and, it could be due to the kidnaping of the
cellular components during parasite multiplication. Considering
that both T. cruzi and HIV replicate intracellularly, they depend
on the host cell energy at adequately high rates. These pathogens
hijack cells in order to multiply, and efficient multiplication
needs a metabolite-enriched host. Therefore, T. cruzi could
diminish apoptosis of HIV-infected cells which may impact on
the establishment of reservoirs. Comparatively, whether T. cruzi
exhibits higher consumption of energy and metabolites than
HIV is not known, but have observed that when parasite
multiplication diminishes it allows higher HIV replication.
Furthermore, the same parasite-mediated downregulation on the
HIV replication was observed with two different T. cruzi parasite
populations (K98 of DTU I andCL of DTUVI) genetically distant
but sharing similar replication rates in the system used (data
not shown). These data were further supported when we treated
HIV-T. cruzi coinfected astrocytes with benznidazole, leading to
viral replication recovery. These observations suggest that the T.
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FIGURE 7 | Impact of the soluble factors on HIV replication and IL-6 level. (A) Schematic depiction of the setup for a transwell assay with the upper surface (US)
separated from the bottom surface (BS) by a membrane with 0.4-µm pores. (B) p24 antigen level (ng/mL) in culture supernatant in four different conditions. All cells in
the bottom surface were infected with HIV. Four different conditions were fixed to the upper surface: (i) T. cruzi free stage (trypomastigote) (TcF), (ii) astrocytes infected
with T. cruzi (Tc), (iii) empty (−), and (iv) uninfected astrocytes (U). The cell viability in the bottom surface was measured by propidium iodide (PI+) by flow cytometry at
5 dpi (**P < 0.01). (C) IL-6 level in the culture supernatant was measured in six different conditions. In the bottom surface, cells were infected with HIV (+) except for
two of them (Ctrl: uninfected cells; TcC: cells infected with Tc only). In the upper surface, astrocytes infected with T. cruzi (Tc), empty (−), uninfected astrocytes (U), and
T. cruzi free stage (trypomastigote) (TcF). The cell viability in the bottom surface was measured by propidium iodide (PI+) by flow cytometry at 5 dpi (*P < 0.05, and
**P < 0.01).
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FIGURE 8 | Trypanosoma cruzi infection impairs herpes simplex type-2 (HSV-2) replication. (A) HSV-2 titration by plaque-forming-units assay in Vero cells showing
plaques developed by HSV-2 (G-strain) in Vero cell cultures 48 h after viral monoinfection (columns identified as “HSV”), or parasite + viral coinfection (columns
identified as “Tc/HSV”) and stained with crystal violet, as described in Section Materials and Methods. Each line represents an HSV-2 inoculum or multiplicity of
infection –m.o.i- (0.1; 0.01; 0.001). “Ctrl”: Non-infected cells (“MOCK”) and T. cruzi mono-infected cells (“Tc”). (B) Fold-change in HSV-2 DNA between HSV-2
monoinfection, and Tc/HSV-2 coinfection. Two-tailed paired Student t-test P-values indicate statistical significance (***P < 0.001).
cruzimultiplication rate could be a relevant factor in driving HIV
progeny.
In conclusion, human astrocytes can concurrently host both
T. cruzi and HIV. This scenario favors interactions between
both pathogens without the requirement of cohabiting a cell or
infected cell-to-cell contact. Moreover,T. cruzi decreases both the
level of HIV replication as well as astrocyte apoptosis by cellular
(IL-6) and parasite-release soluble factors are involved. These
data provide novel insights into pathogenesis of T. cruzi-HIV
coinfection at the CNS level, raising new challenges for future
research on parasite-HIV-host interaction.
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